ACAD vs PPL · P/E 15, rev $576.0M vs P/E 22, rev $9.04B
ACADIA Pharmaceuticals Inc (ACAD) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the ACAD and PPL stock pages for the full models.
Not investment advice.